US Stock MarketDetailed Quotes
ASMB Assembly Biosciences
- 14.900
- +0.210+1.43%
Close Oct 4 16:00 ET
- 14.900
- 0.0000.00%
Post 20:02 ET
94.55MMarket Cap-1714P/E (TTM)
14.960High14.110Low11.93KVolume14.830Open14.690Pre Close173.81KTurnover0.31%Turnover RatioLossP/E (Static)6.35MShares20.04052wk High2.73P/B57.16MFloat Cap7.69252wk Low--Dividend TTM3.84MShs Float1260.000Historical High--Div YieldTTM5.79%Amplitude7.692Historical Low14.565Avg Price1Lot Size
Assembly Biosciences Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -25.49%-17.1M | 21.62%-18.36M | 126.93%22.74M | 482.50%73.65M | 30.14%-13.85M | 23.80%-13.63M | 14.81%-23.43M | 9.56%-84.46M | 0.56%-19.25M | -4.98%-19.82M |
| Net income from continuing operations | 34.00%-11.15M | 52.10%-9.08M | 34.23%-61.23M | 51.05%-10.96M | 37.70%-14.42M | 30.93%-16.9M | 17.93%-18.95M | 28.31%-93.09M | 62.83%-22.4M | -23.09%-23.15M |
| Operating gains losses | ---- | ---- | --139K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -74.60%32K | -74.19%32K | -9.64%450K | -32.26%84K | -13.43%116K | 5.00%126K | 3.33%124K | 6.87%498K | 3.33%124K | 12.61%134K |
| Other non cash items | -58.55%354K | -58.01%359K | 0.06%3.51M | 14.05%982K | -5.12%816K | -4.15%854K | -4.26%855K | -8.72%3.51M | -4.33%861K | -4.76%860K |
| Change In working capital | -590.06%-6.21M | -26.42%-9.15M | 3,697.60%76.34M | 37,510.81%83.5M | -256.97%-1.18M | -67.67%1.27M | -3.19%-7.24M | 81.39%-2.12M | -86.43%222K | 126.50%753K |
| -Change in receivables | -88.53%43K | --0 | 248.19%901K | -114.24%-43K | 147.30%342K | 37,400.00%375K | 220.74%227K | -168.01%-608K | -30.25%302K | -53.18%-723K |
| -Change in prepaid assets | -79.22%437K | 59.20%-652K | -31.02%916K | 95.22%-35K | -76.54%446K | 1,129.82%2.1M | -13,216.67%-1.6M | 19.75%1.33M | -190.71%-732K | 622.25%1.9M |
| -Change in payables and accrued expense | 805.76%2.08M | 59.08%-2.25M | -41,814.29%-5.84M | -2.82%827K | -290.75%-866K | -107.14%-295K | -1.57%-5.51M | 100.17%14K | -23.13%851K | -54.10%454K |
| -Change in other current assets | --0 | --0 | -29.12%577K | -66.85%240K | -1,100.00%-220K | -99.63%2K | 217.58%555K | -82.64%814K | 230.59%724K | -99.47%22K |
| -Change in other current liabilities | 74.07%-238K | 49.56%-463K | -2.83%-3.77M | -14.19%-1.05M | 1.89%-884K | 0.54%-918K | 0.54%-918K | 3.06%-3.67M | 0.75%-923K | 1.21%-901K |
| -Change in other working capital | ---8.53M | ---5.79M | --83.56M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -25.49%-17.1M | 21.62%-18.36M | 126.93%22.74M | 482.50%73.65M | 30.14%-13.85M | 23.80%-13.63M | 14.81%-23.43M | 9.56%-84.46M | 0.56%-19.25M | -4.98%-19.82M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 161.05%5.11M | 72.72%17.27M | -176.28%-69.14M | -641.32%-89.65M | -39.93%18.88M | -187.16%-8.37M | -69.74%10M | 241.84%90.64M | 295.21%16.56M | 56.61%31.43M |
| Net PPE purchase and sale | 70.83%-14K | ---14K | -126.47%-231K | ---47K | -33.33%-136K | ---48K | --0 | 95.44%-102K | --0 | ---102K |
| Net business purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 0.00%1.5M | ---- | ---- |
| Net investment purchase and sale | 161.57%5.12M | 72.86%17.29M | -177.21%-68.91M | -694.92%-89.61M | -39.69%19.02M | -186.66%-8.32M | -69.74%10M | 227.45%89.24M | 251.13%15.06M | 57.12%31.53M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 161.05%5.11M | 72.72%17.27M | -176.28%-69.14M | -641.32%-89.65M | -39.93%18.88M | -187.16%-8.37M | -69.74%10M | 241.84%90.64M | 295.21%16.56M | 56.61%31.43M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 9,194.03%12.45M | 0 | 2,150.49%13.82M | 2,003.43%9.19M | 0 | -24.29%134K | 4.49M | -98.84%614K | -83.89%437K | 0 |
| Net common stock issuance | 22,853.70%12.4M | --0 | 4,112.00%13.69M | 2,713.23%9.14M | --0 | --54K | --4.49M | -99.38%325K | -87.50%325K | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | -55.36%129K | -56.25%49K | --0 | ---- | ---- | 12.02%289K | -1.75%112K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 9,194.03%12.45M | --0 | 2,150.49%13.82M | 2,003.43%9.19M | --0 | -24.29%134K | --4.49M | -98.84%614K | -83.89%437K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -56.88%18.75M | -62.15%19.84M | 14.88%52.42M | -51.24%26.66M | -49.79%21.62M | -15.03%43.48M | 14.88%52.42M | -23.24%45.63M | -22.73%54.67M | -27.65%43.06M |
| Current changes in cash | 102.10%459K | 87.78%-1.09M | -579.71%-32.58M | -202.22%-6.82M | -56.65%5.03M | -169.50%-21.86M | -261.10%-8.94M | 149.15%6.79M | 91.03%-2.26M | 3.26%11.61M |
| End cash Position | -11.17%19.21M | -56.88%18.75M | -62.15%19.84M | -62.15%19.84M | -51.24%26.66M | -49.79%21.62M | -15.03%43.48M | 14.88%52.42M | 14.88%52.42M | -22.73%54.67M |
| Free cash flow | -25.15%-17.12M | 21.56%-18.38M | 126.59%22.49M | 482.13%73.58M | 29.81%-13.98M | 23.53%-13.68M | 14.81%-23.43M | 12.36%-84.57M | 0.65%-19.25M | -5.52%-19.92M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data